Search - Archive ouverte HAL Access content directly

Filter your results

10 Results
Author: personID (integer) : 785976

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy , Emmanuelle Le Chatelier , Lisa Derosa , Connie Duong , Maryam Tidjani Alou et al.
Science, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles hal-02126484v1
Image document

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

Solenn Brosseau , Claire Danel , Arnaud Scherpereel , Julien Mazières , Sylvie Lantuejoul et al.
Clinical Lung Cancer, 2019, 20 (5), pp.e564-e575. ⟨10.1016/j.cllc.2019.04.010⟩
Journal articles hal-02511543v1

Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study

Pierre Mordant , Solenn Brosseau , Bernard Milleron , Nicola Santelmo , Séverine Fraboulet-Moreau et al.
Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩
Journal articles hal-03800571v1
Image document

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

Elodie Maille , Solenn Brosseau , Vincent Hanoux , Christian Creveuil , Claire Danel et al.
British Journal of Cancer, 2019, 120 (4), pp.387-397. ⟨10.1038/s41416-019-0379-8⟩
Journal articles hal-02103278v1
Image document

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

Maureen Keller , Fatéméh Dubois , Sylvain Teulier , Alexandre Martin , Jérôme Levallet et al.
Journal of Experimental and Clinical Cancer Research, 2019, 38 (158), pp.158. ⟨10.1186/s13046-019-1145-8⟩
Journal articles hal-02086738v1

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson , Alexandre Thibault Jacques Maria , Florence Poizeau , François-Xavier Danlos , Marie Kostine et al.
Journal for Immunotherapy of Cancer, 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Journal articles hal-02530293v1

Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience

Jean Philippe Spano , Marianne Veyri , Aurélien Gobert , Amelie Guihot , Philippe Perré et al.
AIDS. Official journal of the international AIDS Society, 2019, 33 (11), pp.F13-F19. ⟨10.1097/QAD.0000000000002298⟩
Journal articles hal-02591390v1

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

Pascale Tomasini , Solenn Brosseau , Julien Mazières , Jean Merlio , Michèle Beau-Faller et al.
European Respiratory Journal, 2017, 50 (2), pii: 1700514. ⟨10.1183/13993003.00514-2017⟩
Journal articles hal-01699297v1

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer

Marine Baron , Cathia Soulié , Armelle Lavolé , Lambert Assoumou , Baptiste Abbar et al.
Cells, 2022, 11 (6), pp.1015. ⟨10.3390/cells11061015⟩
Journal articles hal-03633068v1

Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial

Armelle Lavole , Julien Mazieres , Sophie Schneider , Solenn Brosseau , Lize Kiakouama et al.
Lung Cancer, 2021, 158, pp.146-150. ⟨10.1016/j.lungcan.2021.05.031⟩
Journal articles hal-03524445v1